Basic Research

HOME > R&D Achievement > Basic Research > Article
 
DATE : 16-03-13 12:38
Biodegradable Polymer-Based Sirolimus Coating Stent in a Porcine Coronary Restenosis Model.
 WRITER : stent
HIT : 1,147  
   B60._Clin_Exp_Thromb_Hemost_2014;1_2_59-65..pdf (2.6M) [0] DATE : 2016-03-13 12:38:56
B60. Lim KS, Park JK, Jeong MH, Bae IH, Nah JW, Park DS, Kim JM, Kim JH, Lee SY, Jang EJ, Kim NY, Sim DS, Park KH, Hong YJ, Ahn Y, Kang JC; Biodegradable Polymer-Based Sirolimus Coating Stent in a Porcine Coronary Restenosis Model. Clin Exp Thromb Hemost 2014;1(2)59-65.

(Abstract)
Purpose
Biolimus A9 is a highly lipophilic derivative of sirolimus. The aim of this study was to compare a sirolimus- and a biolimus A9-eluting stent using the same biodegradable polymer (PLA, poly-L-lactic acid) in a porcine coronary overstretch restenosis model.
Methods
Pigs were randomized into three groups in which the coronary arteries (15 pigs, 10 coronaries in each group) had either sirolimus-eluting stents with PLA (SEP, n = 10), biolimus A9-eluting stents with PLA (BEP, n = 10), or PLA-coated stents (PCS, n = 10). Histopathologic analysis was performed at 28 days after stenting.
Results
In the release profiles, approximately 40% of the sirolimus and 50% of the biolimus A9 were released from the stent for 32 days. There were no significant differences in the injury score and the internal elastic lamina. Among the three groups, there were significant differences in the lumen area (3.2±0.91 mm2 in SEP vs. 3.1±1.10 mm2 in BEP vs. 0.5±0.56 mm2 in PCS, P<0.0001), in the neointimal area (1.7±0.56 mm2 in SEP vs. 1.9±0.95 mm2 in BEP vs. 4.3±0.63 mm2 in PCS, P<0.0001), in the percent area of stenosis (35.2±13.77% in SEP vs. 39.0±20.00% in BEP vs. 89.4±10.92% in PCS, P<0.0001), in the fibrin score [2.0 (range 1.0 to 3.0) in SEP vs. 2.0 (range 2.0 to 3.0) in BEP vs. 1.0 (range 1.0 to 2.0) in PCS, P<0.0001], and in the inflammation score [1.0 (range 1.0 to 2.0) in SEP vs. 1.0 (range 1.0 to 3.0) in BEP vs. 3.0 (range 2.0 to 3.0) in PCS, P<0.0001]. The percent area of stenosis using micro-computed tomography demonstrated similar restenosis rates with histopathological stenosis between SEP and BEP (36.7±13.77% in SEP vs. 41.2±20.00% in BEP vs. 86.5±10.92% in PCS).
Conclusion
SEP and BEP showed a superior neointima suppressive effect compared to PCS at one month after stenting in a porcine coronary restenosis model. Therefore, sirolimus with biodegradable polymers can be a useful and selective drug for coating the coronary stent to inhibit neointimal hyperplasia.